Randomised Controlled Trial of Mechanistic Effects of Rifaximin in Cirrhosis and Chronic Hepatic Encephalopathy
Conditions
- Liver Cirrhosis
- Hepatoencephalopathy, Early Fatal Progressive
Interventions
- DRUG: Rifaximin-α
- DRUG: Placebo Oral Tablet
Sponsor
King's College Hospital NHS Trust
Collaborators